With regard to the intrinsic value, I keep returning to the fact that they have a product approved in Europe that seems to work in a condition with few options. As a form of radiotherapy it’s much less problematic and higher dose than external beam radiotherapy.
I know things could be better, approvals extended to Folfirinox, RCT evidence for reimbursement etc etc. But they have an actual marketable product that seems to reduce the size of the cancer. So many other companies have nothing yet and yet have much higher market value.
With regard to the intrinsic value, I keep returning to the fact...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
0.015(1.48%) |
Mkt cap ! $14.65M | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.05 | 95.0¢ | $109.7K | 112.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23906 | $1.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.05 | 2292 | 2 |
View Market Depth
| Last trade - 15.57pm 19/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |